Ventrus Biosciences (VTUS) Acquisition of Title to Hemorrhoids ProductWelcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Ventrus BioSciences Incorporated - symbol VTUS - reported that it has completed its acquisition of all rights and title to VEN 309 - iferanserin ointment for the treatment of symptomatic hemorrhoids - from the licensor, Sam Amer & Company.
